Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

October 1, 2018

Study Completion Date

January 1, 2019

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

Thora-3Di

Device that uses a grid of structured light to measure chest and abdominal wall movement

DEVICE

Body Plethysmography

A pulmonary function test (PFT) for measuring total lung volume.

DEVICE

Spirometry

A pulmonary function tests (PFT) for measuring maximal forced expiratory flow and volume.

Trial Locations (1)

93003

Ventura County Medical Center, Ventura

All Listed Sponsors
collaborator

Pneumacare Ltd

INDUSTRY

lead

Landon Pediatric Foundation

OTHER

NCT03492359 - Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter